Tin t&#x1EE9;c &amp; C&#x1EAD;p nh&#x1EAD;t

Paediatricians and other healthcare providers should treat childhood obesity immediately and at the highest level of intensity appropriate for and available to children, according to the new guideline published by the American Academy of Pediatrics (AAP).

17 Feb 2023

BMI mediates effects of statins on diabetes risk

Higher body mass index (BMI) plays a significant role in more than half of the diabetogenic effects of statins, reports a study. These effects, however, do not extend to other commonly used lipid modifiers.

Counselling, pamphlets boost flu vaccine intake in SG

Use of educational pamphlets alone and individualized counselling (IC) both lead to improved uptake of influenza vaccination, reports a Singapore study, noting that IC is not superior to pamphlets alone in increasing uptake.

17 Feb 2023

GLP-1 agonists induce weight loss in diabetic patients with obesity

Initiation of a glucagon-like peptide-1 (GLP-1) agonist at standard glycaemic control doses may result in modest weight loss through 72 weeks in patients with overweight or obesity and type 2 diabetes, suggest the results of a real-world study.

17 Feb 2023

Almonds beneficial for Asian Indians with overweight, obesity

Almond consumption led to improvements in cardiometabolic, glycaemic, and insulin markers in Asian Indian adults with overweight and obesity, a study has shown.

17 Feb 2023

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension

In women with postpartum hypertension, treatment with combined hydrochlorothiazide (HCTZ)/lisinopril yields greater blood pressure (BP)-lowering benefit than nifedipine monotherapy, according to the results of a pilot study.

17 Feb 2023

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

Uncontrolled postpartum haemorrhage (PPH) is a life-threatening complication of childbirth that is temporarily managed with uterine balloon tamponade. At SMFM 2023, researchers from the US presented findings for a new device that could control PPH safely and effectively in just 5 minutes.

Novel acid-suppressive agent shows therapeutic potential

The novel potassium-competitive acid blocker zastaprazan (JP-1366) appears to have a rapid and potent gastric acid-suppressive effect, with a single oral dose up to 60 mg and multiple oral doses up to 40 mg being safe and well tolerated, according to a study.

Hypothalamic defects seen in overweight kids with PSIS

Notable phenotypic differences are present in patients with pituitary stalk interruption syndrome (PSIS) who are overweight or obese, which indicate hypothalamic defects, reports a study.

16 Feb 2023

LGBTQI+ Singaporeans face enduring stigma within healthcare

16 Feb 2023 bởi

Stigma continues to prevail for lesbian, gay, bisexual, transgender, queer, and intersex (LGBTQI+) patients within the healthcare setting in Singapore, and this is partly due to the lack of training of medical students, a study has found.